Relief Therapeutics Holding AG

Relief Therapeutics Holding AGverified

RLFTD

Price:

$4.08

Market Cap:

$35.09M

Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lu...[Read more]

Industry

Biotechnology

IPO Date

2021-11-23

Stock Exchange

OTC

Ticker

RLFTD

The Enterprise Value as of November 2025 (TTM) for Relief Therapeutics Holding AG (RLFTD) is 24.49M

According to Relief Therapeutics Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 24.49M. This represents a change of 26.07% compared to the average of 19.42M of the last 4 quarters.

Relief Therapeutics Holding AG (RLFTD) Historical Enterprise Value (quarterly & annually)

How has RLFTD Enterprise Value performed in the past?

The mean historical Enterprise Value of Relief Therapeutics Holding AG over the last ten years is 106.23M. The current 24.49M Enterprise Value has changed 2.21% with respect to the historical average. Over the past ten years (40 quarters), RLFTD's Enterprise Value was at its highest in in the June 2009 quarter at 8.51T. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Quarterly (TTM)
Annual

Average

106.23M

Median

36.02M

Minimum

3.71M

Maximum

606.89M

Relief Therapeutics Holding AG (RLFTD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Relief Therapeutics Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 16.24%

Maximum Annual Enterprise Value = 606.89M

Minimum Annual Increase = -89.46%

Minimum Annual Enterprise Value = 3.71M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202439.86M237.90%
202311.80M-89.46%
2022111.95M-38.83%
2021183.00M-69.85%
2020606.89M16.24%
20193.71M-69.73%
201812.27M-40.90%
201720.76M-46.02%
201638.45M14.47%
201533.59M4.46%

Relief Therapeutics Holding AG (RLFTD) Average Enterprise Value

How has RLFTD Enterprise Value performed in the past?

The current Enterprise Value of Relief Therapeutics Holding AG (RLFTD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

54.53M

5-year avg

190.70M

10-year avg

106.23M

Relief Therapeutics Holding AG (RLFTD) Enterprise Value vs. Peers

How is RLFTD’s Enterprise Value compared to its peers?

Relief Therapeutics Holding AG’s Enterprise Value is less than Abliva AB (publ) (683.00M), less than Medivir AB (publ) (411.40M), less than Small Pharma Inc. (34.37M), less than Alpha Cognition Inc. (34.21M), less than Oncopeptides AB (publ) (1.13B), less than LakeShore Biopharma Co., Ltd (631.05M), less than MedPeer,Inc. (10.63B), less than Mindset Pharma Inc. (66.42M), less than Assisted 4 Living, Inc. (45.15M), less than Herantis Pharma Oyj (50.66M),

Build a custom stock screener for Relief Therapeutics Holding AG (RLFTD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relief Therapeutics Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Relief Therapeutics Holding AG (RLFTD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Relief Therapeutics Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Relief Therapeutics Holding AG's Enterprise Value?

What is the highest Enterprise Value for Relief Therapeutics Holding AG (RLFTD)?

What is the 3-year average Enterprise Value for Relief Therapeutics Holding AG (RLFTD)?

What is the 5-year average Enterprise Value for Relief Therapeutics Holding AG (RLFTD)?

How does the current Enterprise Value for Relief Therapeutics Holding AG (RLFTD) compare to its historical average?